NASDAQ: PCSA
Processa Pharmaceuticals Inc Stock Ownership - Who owns Processa Pharmaceuticals?

Insider buying vs selling

Have Processa Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sian BigoraChief Development Officer2025-04-013,311$0.41
$1.36kSell
Patrick LinChief Business - Strategy Off2025-04-014,814$0.41
$1.98kSell
David 1. YoungPres. Research Development2025-04-015,345$0.41
$2.20kSell

1 of 1

PCSA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCSA insiders and whales buy or sell their stock.

PCSA Shareholders

What type of owners hold Processa Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Besser64.36%1,458,300$4.30MInsider
Justin W. Yorke49.61%1,124,049$3.32MInsider
George K. Ng14.44%327,200$965.24kInsider
Virgil Thompson10.63%240,755$710.23kInsider
Khalid Islam8.54%193,395$570.52kInsider
Robert Michael Floyd7.59%172,061$507.58kInsider
Geraldine Pannu2.54%57,613$169.96kInsider
Jane Street Group LLC1.33%30,190$89.06kInstitution
Khoso Baluch1.23%27,955$82.47kInsider
Vanguard Group Inc1.04%23,586$69.58kInstitution

1 of 4

PCSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCSA3.07%96.93%Net Selling
PMCB9.71%17.43%Net SellingNet Buying
DWTX0.27%99.73%
CDIO1.68%98.32%
CLGN12.04%0.00%

Processa Pharmaceuticals Stock Ownership FAQ

Who owns Processa Pharmaceuticals?

Processa Pharmaceuticals (NASDAQ: PCSA) is owned by 5.08% institutional shareholders, 160.67% Processa Pharmaceuticals insiders, and 0.00% retail investors. James E. Besser is the largest individual Processa Pharmaceuticals shareholder, owning 1.46M shares representing 64.36% of the company. James E. Besser's Processa Pharmaceuticals shares are currently valued at $4.55M.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.